Cargando…

Lenvatinib-induced severe generalized erythematous rash in a patient with hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Matsumoto, Yukari, Fukumoto, Takeshi, Takahashi, Wakako, Nishigori, Chikako
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327660/ https://www.ncbi.nlm.nih.gov/pubmed/37426368 http://dx.doi.org/10.4081/dr.2023.9617

Ejemplares similares

Erythematous papular rash with sparing of folds
por: Yale, Katerina, et al.
Publicado: (2019)

A Case of Malaria Complicated with Erythematous Rash
por: Ganguli, P., et al.
Publicado: (1936)

Erythematous desquamating rash after initiation of chemotherapy
por: Newcomer, Jack, et al.
Publicado: (2023)

Desquamative erythematous rash in a young woman
por: Lim, Delwyn Zhi Jie, et al.
Publicado: (2023)

Glucagonoma syndrome with severe erythematous rash: A rare case report
por: Wang, Zhen-Xia, et al.
Publicado: (2019)

Carbamazepine-induced hepato-splenomegaly with erythematous rashes in a child
por: Mittal, A., et al.
Publicado: (2012)

Cerebral toxoplasmosis with fever and erythematous macular rash: An initial presentation in an advanced HIV infection
por: Barman, Bhupen, et al.
Publicado: (2018)

Tozinameran: Erythematous skin rash with blisters : case report
Publicado: (2022)

Case report: Severe non-pigmenting fixed drug eruption showing general symptoms caused by chondroitin sulfate sodium
por: Otsuka, Haruhiko, et al.
Publicado: (2022)

Erythematous Papular Rash: A Dermatological Feature of COVID-19
por: Sousa Gonçalves, Catarina, et al.
Publicado: (2020)

Diffuse erythematous rash after teneligliptin therapy: A case report
por: Agrawal, Prabhat, et al.
Publicado: (2018)

Lenvatinib-induced Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma
por: Imakura, Takeshi, et al.
Publicado: (2021)

Lenvatinib for Hepatocellular Carcinoma: A Literature Review
por: Hatanaka, Takeshi, et al.
Publicado: (2021)

Basal cell carcinoma developed from an epidermal cyst: A case report and review of the literature
por: Harada, Tomoka, et al.
Publicado: (2021)

Lenvatinib recruits cytotoxic GZMK+CD8 T cells in hepatocellular carcinoma
por: Yamada, Tomoharu, et al.
Publicado: (2023)

Epidermotropic poorly differentiated adenocarcinoma of colon presenting as a diffuse erythematous petechial rash
por: Sardiña, Luis-Antonio, et al.
Publicado: (2019)

Covid-19-vaccine-pfizer-biontech: Erythematous and purpuric rash: 2 case report
Publicado: (2021)

Nephrotic Syndrome Induced by Lenvatinib Treatment for Hepatocellular Carcinoma
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022)

Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2021)

Severe and delayed-onset acneiform eruptions as an adverse reaction to regorafenib
por: Otsuka, Haruhiko, et al.
Publicado: (2022)

Destructive Thyroiditis Induced by Lenvatinib in Three Patients with Hepatocellular Carcinoma
por: Hirooka, Masashi, et al.
Publicado: (2018)

Lenvatinib-Induced Destructive Thyroiditis in a Patient With Hepatocellular Carcinoma
por: Pandya, Anjani, et al.
Publicado: (2021)

Lenvatinib-Induced Tumor Lysis Syndrome in Advanced Hepatocellular Carcinoma
por: Goyal, Manjeet Kumar, et al.
Publicado: (2023)

EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells
por: He, Xiaoping, et al.
Publicado: (2022)

The role of lenvatinib in the era of immunotherapy of hepatocellular carcinoma
por: Lee, Matthew Man Pok, et al.
Publicado: (2023)

Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma
por: Tateai, Yoshikazu, et al.
Publicado: (2023)

Vascular Normalization Caused by Short-Term Lenvatinib Could Enhance Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Tachiiri, Tetsuya, et al.
Publicado: (2023)

An acutely erythematous, oedematous penis and antecubital fossae rash in a patient taking etanercept: a case report
por: Orr, Tim, et al.
Publicado: (2009)

An itchy erythematous papular skin rash as a possible early sign of COVID-19: a case report
por: Serafini, Alice, et al.
Publicado: (2020)

Implications of interleukin-17 in psoriatic lesions as Koebner phenomenon caused by recurrent occupational burns
por: Sato, Ayumi, et al.
Publicado: (2022)

Lenvatinib Might Induce Activation of Host Immunity in Patients with Hepatocellular Carcinoma
por: Nagai, Hidenari, et al.
Publicado: (2023)

Risperidone-induced skin rash
por: Janardhana, Priya, et al.
Publicado: (2016)

Ibrutinib-Induced Skin Rash
por: Kirar, Sudhir, et al.
Publicado: (2021)

Squamous cell carcinoma arising within discoid lupus erythematous lesions: A systematic review
por: Mufti, Asfandyar, et al.
Publicado: (2020)

Impact of branched-chain amino acids and frailty on the management of lenvatinib-related fatigue in patients with hepatocellular carcinoma
por: Shimose, Shigeo, et al.
Publicado: (2021)

Hydroxychloroquine-Induced Reversible Hypomnesis in a Patient with Reticular Erythematous Mucinosis
por: Lin, Qing, et al.
Publicado: (2012)

Cutaneous Septic Embolism Presenting as Erythematous Plaques
por: Galve, Javier, et al.
Publicado: (2013)

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
por: Personeni, Nicola, et al.
Publicado: (2019)

Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma
por: Amioka, Kei, et al.
Publicado: (2022)

Lenvatinib applicability in the therapeutic strategy of patients with hepatocellular carcinoma
por: Merle, Philippe
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dt1i8sh90leat2oafl0fi4g9bk